Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Auxilium profit beats estimates as acquisition boosts sales
Yahoo/Reuters
Wednesday, November 6, 2013 - 8:42am
tags:
Auxilium, earnings
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Bloomberg
Wednesday, November 6, 2013 - 8:34am
tags:
testosterone, Eli Lilly, Actavis, Androgel, Axiron, AbbVie, Androderm
What Cytori Therapeutics Isn't Telling Investors About Its Asian Partner
TheStreet.com
Wednesday, November 6, 2013 - 8:29am
tags:
Cytori
Sexual harassment suit against AstraZeneca removed to federal court
West Virginia Record
Wednesday, November 6, 2013 - 8:28am
tags:
sexual harassment, AstraZeneca
Novartis plots sales cuts in U.K. amid R&D restructuring
Fierce Pharma
Wednesday, November 6, 2013 - 8:27am
tags:
UK, R&D, Novartis, layoffs
3 Biotechs Falling Like a Knife
Motley Fool
Wednesday, November 6, 2013 - 8:26am
tags:
Immunomedics, Inovio, Ariad Pharmaceuticals
Roche Pacing the Field in the Biotech Race
TheStreet.com
Wednesday, November 6, 2013 - 8:20am
tags:
Roche, Amgen, Gilead, Sanofi, Celgene
Karyopharm Therapeutics IPO Looks Promising
Seeking Alpha
Wednesday, November 6, 2013 - 8:19am
tags:
Karyopharm, IPOs, Pfizer, Aveo Oncology, ONYX Pharmaceuticals
Teva's ex-CEO reportedly forced polygraph tests on board to plug media leaks
Fierce Pharma
Tuesday, November 5, 2013 - 3:56pm
tags:
Teva, Jeremy Levin
Zoetis 3rd-quarter net income falls on charges, but company raises guidance for the full year
Yahoo/AP
Tuesday, November 5, 2013 - 3:55pm
tags:
earnings, Zoetis, animal health
Roche's Gazyva Approval Marks Success in Oncology and New FDA Designation
Motley Fool
Tuesday, November 5, 2013 - 3:55pm
tags:
Roche, Gazyva, FDA, CLL, chronic lymphocytic leukemia
Analyst lays out 'doomsday scenario' for federal probe of AstraZeneca's Brilinta
Fierce Biotech
Tuesday, November 5, 2013 - 11:21am
tags:
AstraZeneca, Brilinta
Novartis chopping 371 research jobs in global R&D shakeup
Fierce Biotech
Tuesday, November 5, 2013 - 11:12am
tags:
Novartis, R&D, layoffs
Watch Out: Barbarians At The Gate For Oxygen Biotherapeutics
TheStreet.com
Tuesday, November 5, 2013 - 11:11am
tags:
Oxygen Biotherapeutics
Loss Expected to Widen for Arena Pharmaceuticals
Forbes
Tuesday, November 5, 2013 - 11:10am
tags:
Arena Pharmaceuticals, earnings
Immunogen's 'Smart Bomb' Cancer Drugs Are Flunking Safety Checks
TheStreet.com
Tuesday, November 5, 2013 - 10:15am
tags:
Immunogen, IMGN901
This Diabetes Giant Could Face 3 Major Challenges
Motley Fool
Tuesday, November 5, 2013 - 9:57am
tags:
diabetes, Novo Nordisk, Tresiba, GLP-1 agonist, Victoza
Keryx's kidney drug meets main goals of mid-stage study
Yahoo/Reuters
Tuesday, November 5, 2013 - 9:56am
tags:
Keryx, Zerenex, chronic kidney disease
Regeneron earnings beat forecasts, Eylea outlook higher
Yahoo/Reuters
Tuesday, November 5, 2013 - 9:35am
tags:
earnings, Regeneron
Does Reckitt's drug business make a match with Shire?
Fierce Pharma
Tuesday, November 5, 2013 - 9:24am
tags:
Shire, Reckitt Benckiser, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.